NYRADA INC (NYR)

---

AI Coverage Rating: Active

ASX AI Signals has generated 5 signal for NYR during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest NYR Signals
29/06/2026	SELL
28/06/2026	SELL
27/06/2026	SELL
NYR Share Price
Current Price	$0.440
52 Week High	$1.380
52 Week Low:	$0.235
Trading at (% of 52 Week High)	31.88%

Business Overview

Nyrada Inc (ASX: NYR) is a biotechnology company focused on the research and development of innovative small molecule drugs. The company aims to create treatments for cardiovascular and neurodegenerative diseases. Nyrada's work includes advancing preclinical programs to address major unmet medical needs.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for NYRADA INC is supported by technical indicators and market sentiment suggesting downward pressure. However, the relatively low stock price and potential volatility introduce some uncertainty, moderating the confidence level.

Latest  NYRADA INC(NYR)   News